Regenerative Medical Technology Group Inc. (RMTG) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$5.1M

Net Income/Loss (FY2025)

-$7.8M

Total Assets (FY2025)

$4.5M

Total Equity (FY2025)

-$34.7M

Cash Flows from Operating Activities (FY2025)

-$706.5K

Source: Regenerative Medical Technology Group Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.